Nestlé Health Science logo

Nestlé Health Science

Europe, Vaud, Switzerland, Vevey

Description

Nestlé Health Science is a company that uses nutrition to help people manage their health.

Investor Profile

Nestlé Health Science has made 15 investments, with 0 in the past 12 months and 47% as lead.

Stage Focus

  • Series D (27%)
  • Post Ipo Equity (20%)
  • Series E (13%)
  • Series Unknown (13%)
  • Debt Financing (7%)
  • Series C (7%)
  • Convertible Note (7%)
  • Private Equity (7%)

Country Focus

  • United States (47%)
  • France (27%)
  • Switzerland (13%)
  • China (7%)
  • New Zealand (7%)

Industry Focus

  • Health Care
  • Biotechnology
  • Life Science
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Nutrition
  • Wellness
  • Primary And Urgent Care
  • Beauty
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nestlé Health Science frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 2
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Principia SGR
Europe, Lombardia, Italy, Milan
Co-Investments: 3
European Investment Bank
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Climb Ventures
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Business Opportunities for L'Oréal Development
Europe, Ile-de-France, France, Clichy
Co-Investments: 1
HF
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Takeda
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by Nestlé Health Science?

Timeline

Lausanne, Vaud, Switzerland

Timeline is an operator of a life science company aimed to sell goods that target mitochondrial health for enhanced nutrition.

BiotechnologyHealth CareNutritionWellness
Series DJan 17, 2024
Amount Raised: $64,783,848
Ruipeng Pet Healthcare

Shenzhen, Guangdong, China

Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator.

BeautyHealth CareHospitalMedical
Private EquityDec 23, 2022
ProciseDx

San Diego, California, United States

ProciseDx is a provider of point-of-care testing solutions for use in physician offices, retail clinics, and urgent care.

Health CarePrimary and Urgent Care
Convertible NoteJul 13, 2021
Amount Raised: $13,000,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series EJun 25, 2020
Amount Raised: $51,939,777
Aimmune Therapeutics

Brisbane, California, United States

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityFeb 5, 2020
Amount Raised: $200,000,000
Timeline

Lausanne, Vaud, Switzerland

Timeline is an operator of a life science company aimed to sell goods that target mitochondrial health for enhanced nutrition.

BiotechnologyHealth CareNutritionWellness
Series UnknownApr 2, 2019
Aimmune Therapeutics

Brisbane, California, United States

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityNov 18, 2018
Amount Raised: $98,000,002
Axcella

Cambridge, Massachusetts, United States

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

BiotechnologyLife SciencePharmaceuticalTherapeutics
Series ENov 1, 2018
Amount Raised: $59,000,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Debt FinancingJan 4, 2018
Amount Raised: $48,266,625
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series DJan 1, 2017
Amount Raised: $33,694,390